Search - Institut de cancérologie de l'Ouest Access content directly

Filter your results

94 Results
Deposit type : Notice

Human glioma cell culture: Two FCS-free media could be recommended for clinical use in immunotherapy

Anne Clavreul , Isabelle Jean , Laurence Preisser , Agnès Chassevent , A. Sapin , et al.
In Vitro Cellular & Developmental Biology - Animal, 2009, 45 (9), pp.500-511. ⟨10.1007/s11626-009-9215-4⟩
Journal articles istex hal-03171815v1

In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: Distribution and radiosensitisation efficacy

S. Vinchon-Petit , D. Jarnet , A. Paillard-Giteau , Jean-Pierre Benoît , Emmanuel Garcion , et al.
Journal of Neuro-Oncology, 2010, 97 (2), pp.195-205
Journal articles hal-03171864v1

Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer

Aurore Goineau , Mathilde Colombié , Caroline Rousseau , Sophie Sadot-Lebouvier , Stéphane Supiot
Clinical Nuclear Medicine, 2015, 40 (8), pp.670-671. ⟨10.1097/RLU.0000000000000817⟩
Journal articles inserm-02913647v1

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Karim Fizazi , Laura Faivre , François Lesaunier , Remy Delva , Gwenaëlle Gravis , et al.
Lancet Oncology, 2015, 16 (7), pp.787 - 794. ⟨10.1016/S1470-2045(15)00011-X⟩
Journal articles hal-01914904v1

Niveaux de preuve des nouvelles techniques de radiothérapie du cancer de la prostate

M. Khadige , D. Peiffert , S. Supiot
Cancer/Radiothérapie, 2014, 18 (5-6), pp.501 - 508. ⟨10.1016/j.canrad.2014.06.021⟩
Journal articles hal-01817704v1

Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: A non-comparative randomized phase II trial

Michel Ducreux , Marc Giovannini , Charlotte Baey , Carmen Llacer , Jaafar Bennouna , et al.
Digestive and Liver Disease, 2014, 46 (10), pp.950 - 955. ⟨10.1016/j.dld.2014.06.006⟩
Journal articles hal-01817621v1

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Patricia Pautier , Anne Floquet , Christine Chevreau , Nicolas Penel , Cécile Guillemet , et al.
Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩
Journal articles hal-03623745v1

Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group

Axel Le Cesne , Isabelle Ray-Coquard , Florence Duffaud , Christine Chevreau , Nicolas Penel , et al.
European Journal of Cancer, 2015, 51 (6), pp.742-750. ⟨10.1016/j.ejca.2015.01.006⟩
Journal articles hal-03623749v1

Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience

Hervé Avet-Loiseau , Cyrille Hulin , Loic Campion , Philippe Rodon , Gerald Marit , et al.
Journal of Clinical Oncology, 2013, 31 (22), pp.2806--2809. ⟨10.1200/JCO.2012.46.2598⟩
Journal articles hal-01064339v1


E. Gamelin , J. Metges , Antoine Adenis , Jean-Luc Raoul , Y. Lam , et al.
Annals of Oncology, 2008, 19, pp.131-131
Journal articles hal-00618341v1

Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins

Sophie Trécesson , Yannis Guillemin , Audrey Bélanger , Anne-Charlotte Bernard , Laurence Preisser , et al.
Journal of Biological Chemistry, 2011, 286 (15), pp.12825 - 12838. ⟨10.1074/jbc.M110.186437⟩
Journal articles hal-03388055v1

c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1

Mario Campone , Bélinda Noël , Cécile Couriaud , Morgan Grau , Yannis Guillemin , et al.
Molecular Cancer, 2011, 10 (1), pp.1 - 14. ⟨10.1186/1476-4598-10-110⟩
Journal articles hal-03388075v1

How should we define STAT3 as an oncogene and as a potential target for therapy?

Hélène Sellier , Amélie Rébillard , Catherine Guette , Benjamin Barré , Olivier Coqueret
JAK-STAT, 2013, 2 (3), Non spécifié. ⟨10.4161/jkst.24716⟩
Journal articles hal-03389739v1

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.

Gilles Houvenaeghel , Marie Bannier , Claude Nos , Sylvia Giard , Hervé Mignotte , et al.
Breast, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
Journal articles hal-00760573v1

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Franck Bonnetain , Bert Bonsing , Thierry Conroy , Adelaide Dousseau , Bengt Glimelius , et al.
European Journal of Cancer, 2014, 50 (17), pp.2983 - 2993. ⟨10.1016/j.ejca.2014.07.011⟩
Journal articles hal-01802621v1

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

Georges Noel , Aymeri Huchet , Loic Feuvret , Jean Philippe Maire , Pierre Verrelle , et al.
Journal of Neuro-Oncology, 2012, 109 (1), pp.167-75. ⟨10.1007/s11060-012-0883-7⟩
Journal articles istex hal-00905430v1

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

Gyasi Johnson , Agnès Sallé , Gérard Lorimier , Laurent Laccourreye , Bernard Enon , et al.
Nutrition, 2008, 24 (5), pp.443 - 450. ⟨10.1016/j.nut.2008.01.013⟩
Journal articles istex hal-03267477v1

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial

K. Fizazi , G. Gravis , Aude Flechon , L. Geoffrois , C. Chevreau , et al.
Annals of Oncology, 2014, 25, pp.987--91. ⟨10.1093/annonc/mdu099⟩
Journal articles hal-02168058v1

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial†

E. Deutsch , C. Lemanski , J.-P. Pignon , A. Levy , A. Delarochefordiere , et al.
Annals of Oncology, 2013, 24 (11), pp.2834 - 2838. ⟨10.1093/annonc/mdt368⟩
Journal articles hal-01798389v1

Aerosolized Chemotherapy

Frédéric Gagnadoux , José Hureaux , Laurent Vecellio , Thierry Urban , Alain Le Pape , et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2008, 21 (1), pp.61 - 70. ⟨10.1089/jamp.2007.0656⟩
Journal articles hal-03275617v1

Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft

Emilie Allard-Vannier , D. Jarnet , Anne Vessières , S. Vinchon-Petit , Gérard Jaouen , et al.
Pharmaceutical Research, 2010, 27 (1), pp.56-64
Journal articles hal-03171855v1

Local implantation of doxorubicin drug eluting beads in rat glioma

S. Vinchon-Petit , D. Jarnet , Sophie Michalak , A. Lewis , Jean-Pierre Benoît , et al.
International Journal of Pharmaceutics, 2010, 402 (1-2), pp.184-9
Journal articles hal-03171865v1

External irradiation models for intracranial 9L glioma studies

S. Vinchon-Petit , D. Jarnet , Eric Jadaud , L. Feuvret , Emmanuel Garcion , et al.
Journal of experimental & clinical cancer research, 2010, 29, pp.142. ⟨10.1186/1756-9966-29-142⟩
Journal articles hal-03171878v1

Predictive Power of FDG-PET Parameters at Diagnosis and after Induction in Patients with Mantle Cell Lymphoma, Interim Results from the LyMa-PET Project, Conducted on Behalf of the Lysa Group

Caroline Bodet-Milin , Clément Bailly , Michel Meignan , Alina Beriollo-Riedinger , René-Olivier Casasnovas , et al.
Blood, 2015, 126 (23), pp.335
Journal articles hal-01300802v1

CD95L cell surface cleavage triggers a pro-metastatic signaling pathway in triple negative breast cancer.

Marine Malleter , Sebastien Tauzin , Alban Bessede , Remy Castellano , Armelle Goubard , et al.
Cancer Research, 2013, 73 (22), pp.6711-21. ⟨10.1158/0008-5472.CAN-13-1794⟩
Journal articles hal-00873634v1

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who, when, where and how?

G. Créhange , M. Roach , É. Martin , L. Cormier , D. Peiffert , et al.
Cancer/Radiothérapie, 2014, 18 (5-6), ⟨10.1016/j.canrad.2014.07.153⟩
Journal articles hal-01202918v1

Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial

C. Delbaldo , M. Ychou , A. Zawadi , J. Douillard , T. André , et al.
Annals of Oncology, 2015, 26 (6), pp.1208-1215. ⟨10.1093/annonc/mdv135⟩
Journal articles hal-02285403v1

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

Jean-François Bosset , Gilles Calais , Laurent Mineur , Philippe Maingon , Suzana Stojanovic-Rundic , et al.
Lancet Oncology, 2014, 15 (2), pp.184 - 190. ⟨10.1016/S1470-2045(13)70599-0⟩
Journal articles hal-01822477v1

Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation

Hélène Mounier-Boutoille , Michèle Boisdron-Celle , Estelle Cauchin , Jean-Paul Galmiche , Alain Morel , et al.
British Journal of Clinical Pharmacology, 2010, 70 (2), pp.280 - 283. ⟨10.1111/j.1365-2125.2010.03686.x⟩
Journal articles hal-03388020v1

Two-step OFFGEL approach for effective peptide separation compatible with iTRAQ labeling

Alexis Rideau , Damien Besson , Alice Boissard , Olivier Coqueret , Catherine Guette
Proteomics, 2013, 13 (22), pp.3261 - 3266. ⟨10.1002/pmic.201300161⟩
Journal articles istex hal-03389738v1